Morepen Laboratories Q4 Results
- BSE: 500288
- NSE: MOREPENLAB
- ISIN: INE083A01026
- Sector: Biotechnology & Drugs
BSE
41.96
-0.94 (-2.19%)
-0.94 (-2.19%)Volume1.07 L
Updated: Fri 15 May, 2026 | 15:49:38
NSE
41.94-1.07 (-2.49%)
-1.07 (-2.49%)Volume2.01 M
Updated: Fri 15 May, 2026 | 15:46:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Morepen Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 440.08 | 448.23 | 4.39% | 384.32 | 14.51% |
| Depreciation/ Amortization | 16.47 | 10.38 | 234.04% | 9.62 | 71.12% |
| Operating Income | 25.77 | 35.93 | -17.41% | 38.76 | -33.50% |
| Net Income | 20.32 | 27.51 | -23.88% | 28.28 | -28.16% |
| Other Operating Expenses Total | 26.30 | 42.32 | -29.08% | 53.38 | -50.74% |
| Net Income Before Taxes | 25.71 | 35.42 | -26.96% | 42.20 | -39.07% |
| Total Revenue | 465.85 | 484.16 | 2.89% | 423.07 | 10.11% |
| Selling/ General/ Admin Expenses Total | 69.50 | 87.21 | -13.05% | 64.79 | 7.27% |
| Diluted Normalized EPS | 0.36 | 0.50 | -25.51% | 0.55 | -33.72% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.